Secondary Adjuvant Long Term Study With Arimidex
Clinical trial NCT00295620 · COMPLETED
Trial details
- NCT number
- NCT00295620
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2017-06-30
- Enrollment
- 3484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.